Efficacy and tolerability of MAP0004, a novel orally inhaled therapy, in treating acute migraine

被引：0
|
作者：
Silberstein, S. D. [1 ]
Kori, S. H. [2 ]
Tepper, S. J. [3 ]
Borland, S. W. [2 ]
Wang, M. [2 ]
Reppine, A. E. [2 ]
Armer, T. A. [2 ]
Dodick, D. W. [4 ]
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
[2] MAP Pharmaceut Inc, Mountain View, CA USA
[3] Cleveland Clin, Neurol Ctr Pain, Cleveland, OH 44106 USA
[4] Mayo Clin, Scottsdale, AZ USA
来源：
CEPHALALGIA | 2009年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [21] RESCUE MEDICATION USE IN THE ACUTE TREATMENT OF MIGRAINE DURING MAP0004 PIVOTAL TRIAL
    Kori, S.
    Kellerman, D.
    Chen, S.
    Lu, B.
    VALUE IN HEALTH, 2012, 15 (04) : A149 - A150
  • [22] Efficacy evaluation of LEVADEX™ (previously MAP0004) in treating a broad spectrum of acute migraine attacks including patients using triptans and patients not using triptans
    Winner, P. K.
    Kori, S. H.
    Freitag, F. G.
    Goldstein, J.
    Borland, S. W.
    Wang, M.
    Hu, B.
    Brandes, J. L.
    CEPHALALGIA, 2009, 29 (12) : 1358 - 1358
  • [23] Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics
    Shrewsbury, Stephen B.
    Kori, Shashidhar H.
    Miller, S. David
    Pedinoff, Andrew
    Weinstein, Steven
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (07) : 1977 - 1985
  • [24] Reduced Adverse Event Profile of Orally Inhaled DHE (MAP0004) vs IV DHE: Potential Mechanism
    Cook, Robert O.
    Shrewsbury, Stephen B.
    Ramadan, Nabih M.
    HEADACHE, 2009, 49 (10): : 1423 - 1434
  • [25] Consistency of Migraine Pain Relief after Repeated Administration of MAP0004
    Kori, Shashidhar
    Lu, Biao
    Connors, Emilee
    Li, Xiaodong
    Kellerman, Donald
    NEUROLOGY, 2013, 80
  • [26] Efficacy and tolerability of LEVADEX in treating acute migraine
    Kori, S. H.
    Silberstein, S.
    Aurora, S.
    Borland, S.
    Wang, M.
    Dodick, D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 23 - 23
  • [27] Efficacy and Tolerability of Levadex in Treating Acute Migraine
    Kori, Shashidhar H.
    Silberstein, Stephen
    Aurora, Sheena
    Tepper, Stewart J.
    Borland, Scott
    Wang, Min
    Dodick, David
    ANNALS OF NEUROLOGY, 2010, 68 (04) : S13 - S13
  • [28] Assessment of the consistency of pharmacokinetic parameters of levadex™ (map0004, orally inhaled dihydroergotamine) in healthy volunteers - results from 3 clinical studies
    Forst, A.
    Iwashita, J.
    Kellerman, D.
    Kori, S.
    Thomas, T.
    Taylor, G.
    CEPHALALGIA, 2011, 31 (01) : 82 - 82
  • [29] Assessment of the Consistency of Pharmacokinetic Parameters of LEVADEX™ (MAP0004, Orally Inhaled Dihydroergotamine) in Healthy Volunteers - Results from 3 Clinical Studies
    Forst, A.
    Iwashita, J.
    Kellerman, D.
    Kori, S.
    Thomas, T.
    Taylor, G.
    HEADACHE, 2011, 51 : 22 - 22
  • [30] Assessing the Consistency of LEVADEX™ (MAP0004, Orally Inhaled Dihydroergotamine) Pharmacokinetic Parameters in Healthy Volunteers: Results from 3 Clinical Studies
    Forst, Amy
    Iwashita, Julie
    Kellerman, Don
    Kori, Shashidhar
    Thomas, Tracy
    Taylor, Glyn
    ANNALS OF NEUROLOGY, 2011, 70 : S64 - S64
12345